Cargando…
Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use
BACKGROUND: Patients diagnosed as diffuse large B cell lymphoma (DLBCL) with CD5 positive normally have a worse outcome and poorly respond to the regulatory treatment strategy. RESULTS: We recently reported differently expressed tRFs and their potential target-genes of tRFs in patients with CD5+ R/R...
Autores principales: | Qu, Qingyuan, Li, Ying, Fang, Xiaosheng, Zhang, Lingyan, Xue, Chao, Ge, Xueling, Wang, Xin, Jiang, Yujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882323/ https://www.ncbi.nlm.nih.gov/pubmed/31775867 http://dx.doi.org/10.1186/s13062-019-0255-8 |
Ejemplares similares
-
mt tRFs, New Players in MELAS Disease
por: Meseguer, Salvador, et al.
Publicado: (2022) -
tRFs and tRNA Halves: Novel Cellular Defenders in Multiple Biological Processes
por: Hou, Jiani, et al.
Publicado: (2022) -
Identification of tRFs and phasiRNAs in tomato (Solanum lycopersicum) and their responses to exogenous abscisic acid
por: Luan, Wei, et al.
Publicado: (2020) -
Comprehensive annotation and characterization of planarian tRNA and tRNA-derived fragments (tRFs)
por: Lakshmanan, Vairavan, et al.
Publicado: (2021) -
tRNA deamination by ADAT requires substrate-specific recognition mechanisms and can be inhibited by tRFs
por: Roura Frigolé, Helena, et al.
Publicado: (2019)